Suppr超能文献

一种针对埃可病毒细胞受体的单克隆抗体在人成纤维细胞和猴肾细胞系中的保护作用。

Protective effect of a monoclonal antibody specific for an echovirus cellular receptor in human fibroblast and simian kidney cell lines.

作者信息

Mbida A D, Pozzetto B, Grattard F, Gaudin O G

机构信息

Laboratoire de Virologie, Faculté de Médecine Jacques Lisfranc, France.

出版信息

Res Virol. 1992 Nov-Dec;143(6):397-400. doi: 10.1016/s0923-2516(06)80132-9.

Abstract

We previously reported that infection of KB cells by echoviruses (EV) was inhibited by a KB-derived EV receptor murine monoclonal antibody (mAb 143). This antibody enabled the identification of a cellular receptor common to all echoviruses (with the exception of EV-22 and -23) and coxsackievirus (CV) A9, but different from the receptor of other picornaviruses. We now present results of cell protection assays conducted with human and simian cell lines different from the KB cell line used for production of mAb 143. When human embryonic lung fibroblasts were pretreated with 150 micrograms/ml of mAb 143, EV-11 and CV-A9 were completely inhibited (more than a 2-log difference compared to untreated cells). When the cell protection experiments were performed with Vero cells, the same results were observed with EV-33, but not with EV-22. The protection afforded human fibroblast cells by mAb 143 persisted for at least 5 days after 2-h exposure to 100 TCID50 of EV-11. These results suggest that EV receptors can be effectively blocked for prolonged periods in susceptible cells.

摘要

我们先前报道过,柯萨奇病毒(EV)对KB细胞的感染可被一种源自KB细胞的EV受体鼠单克隆抗体(单克隆抗体143)所抑制。该抗体能够识别所有柯萨奇病毒(EV - 22和 - 23除外)以及柯萨奇病毒A9(CV - A9)共有的一种细胞受体,但不同于其他微小核糖核酸病毒的受体。我们现在展示了使用与用于生产单克隆抗体143的KB细胞系不同的人源和猴源细胞系进行细胞保护试验的结果。当用人胚肺成纤维细胞预先用150微克/毫升的单克隆抗体143处理时,EV - 11和CV - A9被完全抑制(与未处理细胞相比差异超过2个对数级)。当用Vero细胞进行细胞保护实验时,EV - 33出现了相同的结果,但EV - 22没有。在用人成纤维细胞与100个半数组织培养感染剂量(TCID50)的EV - 11接触2小时后,单克隆抗体143提供的保护作用持续了至少5天。这些结果表明,在易感细胞中,EV受体可被有效阻断较长时间。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验